Philips Intracardiac Echocardiography (ICE) Clinical Registry

Completed

Conditions studied: Atrial Fibrillation, Stroke, Valve Disease, Heart, Atrial Septal Defect, Patent Foramen Ovale, Mitral Valve Disease, Tricuspid Valve Disease, Aortic Valve Disease

In brief

The purpose of this observational registry is to report real-world safety and performance of VeriSight for ultrasound guided ICE imaging in percutaneous cardiac intervention procedures when used in standard clinical practice.

Key facts

Study ID

NCT04950192

Run by

Philips Clinical & Medical Affairs Global

People needed

155

Starts

2021-10-25

Expected to finish

2023-07-30

Last updated by the study team

2025-01-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age and willing to provide written, dated and signed, informed consent
• Scheduled for a procedure that is within the scope of clinical indication for VeriSight per Instructions for Use (IFU)

You may not qualify if…

• Contraindicated for ICE catheter placement or patient considerations that make placement of VeriSight not technically feasible
• If alternate access (as needed instead of femoral) is not viable
• Known contraindicated conditions include sepsis, major coagulation abnormalities, presence of any intracardiac thrombus, presence of class IV angina or heart failure, deep vein thrombosis, or significant peripheral vascular disease.

Where it is running

• University of Colorado — Aurora, Colorado, United States
• Northwestern University — Chicago, Illinois, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Texas Cardiac Arrhythmia Research Foundation — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.